We found 76 results.
News
RevealDx’s precision medicine software for lung nodule risk analysis receives regulatory clearance in Australia and New Zealand
...one person every hour. Australians are commonly diagnosed late, 42 percent receiving their diagnosis as stage IV (the most advanced), when their likelihood of surviving five years is less than...
News
Onsite Women’s Health and Volpara Health Announce National Partnership
...cancer. If a breast is not positioned properly – cancer can be missed. With their advanced image analysis technology and common quality measures applied across the organization, Volpara will provide...
News
Rezolut adopts innovative, AI breast care solution from Volpara Health
...care to patients, as well to provide the most advanced technologies to help find cancers early. Rezolut is a national, emerging platform of diagnostic medical imaging services, serving patients across...
News
Volpara Health Receives FDA Clearance for Next-Generation Breast Density Algorithm and Architecture
...mission—to eliminate advanced-stage breast cancer and save more families from cancer,” said Ralph Highnam, Ph.D., Group CEO of Volpara About Volpara Volpara provides an advanced AI software platform that works...
News
Volpara Health Announces Jill Spear as New Executive Vice President of Sales & Marketing
...centers. With more than 30 years of breast health industry experience, Spear is uniquely equipped to help strategically accelerate Volpara’s mission to save families from cancer by preventing advanced stage...
News
Volpara Health and LehYup Partner on Cancer Risk Assessment Services at RSNA 2023
...meeting, November 26-29, 2023 (South Hall, Booth #2780). LehYup LLC, an IT integration and optimization firm, will work alongside Volpara’s professional services and deployment staff by providing advanced Epic® build...
News
Volpara Acquires Breast Cancer Risk Assessment Company CRA Health, LLC.
...established with the main genetics companies. CRA brings world-class knowledge about risk and genetics. CRA will accelerate us on our mission to save families from cancer by preventing advanced stage...
News
Lunit Completes Acquisition of Volpara: Pioneering Next-Level of AI-Driven Cancer Care
...through AI. Strategic Impact: The acquisition of Volpara significantly boosts Lunit’s capabilities in AI-driven cancer diagnostics. With this acquisition, Lunit integrates Volpara’s advanced breast health platform—such as breast density assessment,...
News
Volpara, a Lunit Company, Secures U.S. Defense Health Agency Contract to Modernize Mammography Services
Volpara’s Patient Hub™ will deliver advanced mammography reporting and risk assessment to enhance breast cancer screening across military health facilities LYNNWOOD, WA, November 4, 2024 — Volpara Health, a Lunit...
News
Volpara to Highlight Growing AI Suite for Mammography at ECR 2024, Including New Lunit Distribution Agreement
...and Lunit marks a significant milestone in the evolution of mammography solutions,” said Brandon Suh, CEO of Lunit. “By combining Volpara’s advanced tools with Lunit’s AI solution into one software...
